{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:00:04Z","timestamp":1790470804693,"version":"4.1.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The sickle hemoglobin (HbS) point mutation has independently undergone evolutionary selection at least five times in the world because of its overwhelming malarial protective effects in the heterozygous state. In 1949, homozygous Hb S or sickle cell disease (SCD) became the first inherited condition identified at the molecular level; however, since then, both SCD and heterozygous Hb S, sickle cell trait (SCT), have endured a long and complicated history. Hasty adoption of early mass screening programs for SCD, recent implementation of targeted screening mandates for SCT in athletics, and concerns about stigmatization have evoked considerable controversy regarding research and policy decisions for SCT. Although SCT is a largely protective condition in the context of malaria, clinical sequelae, such as exercise-related injury, renal complications, and venous thromboembolism can occur in affected carriers. The historical background of SCD and SCT has provided lessons about how research should be conducted in the modern era to minimize stigmatization, optimize study conclusions, and inform genetic counseling and policy decisions for SCT.<\/jats:p>","DOI":"10.1182\/asheducation-2015.1.160","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T11:23:25Z","timestamp":1473938605000},"page":"160-167","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":122,"title":["Sickle cell trait diagnosis: clinical and social implications"],"prefix":"10.1182","volume":"2015","author":[{"given":"Rakhi P.","family":"Naik","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlton","family":"Haywood","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD; and"},{"name":"Johns Hopkins Berman Institute of Bioethics, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2835","key":"2019111706064804700_B1","first-page":"443","article-title":"Sickle cell anemia, a molecular disease","volume":"109","author":"Pauling","year":"1949","journal-title":"Science"},{"issue":"2","key":"2019111706064804700_B2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.endeavour.2007.05.009","article-title":"The first \u201cmolecular disease\u201d: a story of Linus Pauling, the intellectual patron","volume":"31","author":"Gormley","year":"2007","journal-title":"Endeavour"},{"issue":"4","key":"2019111706064804700_B3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0035-9203(54)90101-7","article-title":"The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria","volume":"48","author":"Allison","year":"1954","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"2019111706064804700_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/genetics\/153.1.1","article-title":"JBS Haldane (1949) on infectious disease and evolution","volume":"153","author":"Lederberg","year":"1999","journal-title":"Genetics"},{"issue":"6","key":"2019111706064804700_B5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(12)70055-5","article-title":"Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis","volume":"12","author":"Taylor","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2019111706064804700_B6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1182\/blood.V4.1.66.66","article-title":"A rapid diagnostic test for sickle cell anemia","volume":"4","author":"Itano","year":"1949","journal-title":"Blood"},{"issue":"5","key":"2019111706064804700_B7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/ajcp\/62.5.664","article-title":"Evaluation of proficiency in the performance of tests for abnormal hemoglobins","volume":"62","author":"Schmidt","year":"1974","journal-title":"Am J Clin Pathol"},{"key":"2019111706064804700_B8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-60-3-465","article-title":"Sickle Cell trait and superior longitudinal sinus thrombosis","volume":"60","author":"Schenk","year":"1964","journal-title":"Ann Intern Med"},{"key":"2019111706064804700_B9","unstructured":"The American Presidency Project Richard Nixon, Statement on Signing the National Sickle Cell Anemia Control Act 1972 5 16 Accessed April 29, 2015 http:\/\/www.presidency.ucsb.edu\/ws\/?pid=3413"},{"issue":"2","key":"2019111706064804700_B10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.semperi.2009.12.006","article-title":"History and current status of newborn screening for hemoglobinopathies","volume":"34","author":"Benson","year":"2010","journal-title":"Semin Perinatol"},{"issue":"2","key":"2019111706064804700_B11","first-page":"197","article-title":"The cooperative study of sickle cell disease: review of study design and objectives","volume":"4","author":"Gaston","year":"1982","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"9","key":"2019111706064804700_B12","first-page":"1205","volume":"258","author":"Consensus conference","year":"1987","journal-title":"Newborn screening for sickle cell disease and other hemoglobinopathies"},{"issue":"25","key":"2019111706064804700_B13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial","volume":"314","author":"Gaston","year":"1986","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111706064804700_B14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJM197002052820607","article-title":"Sudden death in sickle-cell trait","volume":"282","author":"Jones","year":"1970","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111706064804700_B15","first-page":"29","article-title":"Medical aspects of sickle hemoglobin in military personnel","volume":"69","author":"Brodine","year":"1977","journal-title":"J Natl Med Assoc"},{"issue":"13","key":"2019111706064804700_B16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM198709243171301","article-title":"Sickle-cell trait as a risk factor for sudden death in physical training","volume":"317","author":"Kark","year":"1987","journal-title":"N Engl J Med"},{"key":"2019111706064804700_B17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1182\/asheducation-2013.1.632","article-title":"Sickle cell trait testing and athletic participation: a solution in search of a problem?","volume":"2013","author":"Thompson","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"2019111706064804700_B18","first-page":"300","article-title":"Sickle cell trait and sudden death: bringing it home","volume":"99","author":"Mitchell","year":"2007","journal-title":"J Natl Med Assoc"},{"issue":"11","key":"2019111706064804700_B19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMp1007639","article-title":"Screening student athletes for sickle cell trait: a social and clinical experiment","volume":"363","author":"Bonham","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111706064804700_B20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/07448481.2014.902840","article-title":"Athletes' perceptions of National Collegiate Athletic Association-mandated sickle cell trait screening: insight for academic institutions and college health professionals","volume":"62","author":"Lawrence","year":"2014","journal-title":"J Am Coll Health"},{"issue":"20","key":"2019111706064804700_B21","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2014.15063","article-title":"Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans","volume":"312","author":"Naik","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"2019111706064804700_B22","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajhg.2012.08.031","article-title":"Imputation of exome sequence variants into population- based samples and blood-cell-trait-associated loci in African Americans: NHLBI GO Exome Sequencing Project","volume":"91","author":"Auer","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2019111706064804700_B23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood.V79.3.787.787","article-title":"DNA sequence variation in a negative control region 5\u2032 to the beta-globin gene correlates with the phenotypic expression of the beta s mutation","volume":"79","author":"Elion","year":"1992","journal-title":"Blood"},{"issue":"49","key":"2019111706064804700_B24","first-page":"1155","article-title":"Incidence of sickle cell trait: United States, 2010","volume":"63","author":"Ojodu","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2019111706064804700_B25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(92)90052-D","article-title":"The stigma of disease: implications of genetic screening","volume":"93","author":"Markel","year":"1992","journal-title":"Am J Med"},{"issue":"4058","key":"2019111706064804700_B26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.178.4058.283","article-title":"Sickle cell anemia: national program raises problems as well as hopes","volume":"178","author":"Culliton","year":"1972","journal-title":"Science"},{"issue":"5","key":"2019111706064804700_B27","first-page":"704","article-title":"Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait","volume":"98","author":"Treadwell","year":"2006","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"2019111706064804700_B28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.c.30160","article-title":"Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states","volume":"148C","author":"Kavanagh","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"15","key":"2019111706064804700_B29","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2014.2157","article-title":"Sickle cell trait: neglected opportunities in the era of genomic medicine","volume":"311","author":"Taylor","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"2019111706064804700_B30","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/JSM.0b013e31822e8634","article-title":"Attitudes and beliefs of sports medicine providers to sickle cell trait screening of student athletes","volume":"21","author":"Acharya","year":"2011","journal-title":"Clin J Sport Med"},{"key":"2019111706064804700_B31","doi-asserted-by":"crossref","first-page":"S435","DOI":"10.1016\/j.amepre.2011.09.012","article-title":"Public health implications of sickle cell trait: a report of the CDC meeting","volume":"41","author":"Grant","year":"2011","journal-title":"Am J Prev Med"},{"issue":"3","key":"2019111706064804700_B32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.22271","article-title":"Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications","volume":"87","author":"Goldsmith","year":"2012","journal-title":"Am J Hematol"},{"issue":"4","key":"2019111706064804700_B33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1432-2277.2007.00611.x","article-title":"Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers","volume":"21","author":"Reese","year":"2008","journal-title":"Transpl Int"},{"issue":"5","key":"2019111706064804700_B34","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1542\/peds.2006-1639","article-title":"Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results","volume":"118","author":"Kemper","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"2019111706064804700_B35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/bjh.13363","article-title":"Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory","volume":"170","author":"Key","year":"2015","journal-title":"Br J Haematol"},{"key":"2019111706064804700_B36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/asheducation-2010.1.418","article-title":"Sickle-cell trait: novel clinical significance","volume":"2010","author":"Key","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2019111706064804700_B37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjmed.2008.12.020","article-title":"Complications associated with sickle cell trait: a brief narrative review","volume":"122","author":"Tsaras","year":"2009","journal-title":"Am J Med"},{"issue":"11","key":"2019111706064804700_B38","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1249\/MSS.0b013e31826851c2","article-title":"ACSM and CHAMP summit on sickle cell trait: mitigating risks for warfighters and athletes","volume":"44","author":"O'Connor","year":"2012","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"2019111706064804700_B39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bjsports-2011-090896","article-title":"Sickle cell trait associated with a RR of death of 37 times in National Collegiate Athletic Association football athletes: a database with 2 million athlete-years as the denominator","volume":"46","author":"Harmon","year":"2012","journal-title":"Br J Sports Med"},{"issue":"18","key":"2019111706064804700_B40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM197905033001801","article-title":"Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients","volume":"300","author":"Heller","year":"1979","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111706064804700_B41","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI115521","article-title":"Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait","volume":"88","author":"Gupta","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111706064804700_B42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1681\/ASN.2009070705","article-title":"High prevalence of sickle cell trait in African Americans with ESRD","volume":"21","author":"Derebail","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2019111706064804700_B43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1681\/ASN.2013060575","article-title":"Sickle Trait in African-American Hemodialysis Patients and Higher Erythropoiesis-Stimulating Agent Dose","volume":"25","author":"Derebail","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2019111706064804700_B44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ki.2011.286","article-title":"Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans","volume":"80","author":"Hicks","year":"2011","journal-title":"Kidney Int"},{"issue":"14","key":"2019111706064804700_B45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199204023261402","article-title":"Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme","volume":"326","author":"Falk","year":"1992","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111706064804700_B46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111706064804700_B47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12787","article-title":"Prospective study of sickle cell trait and venous thromboembolism incidence","volume":"13","author":"Folsom","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111706064804700_B48","doi-asserted-by":"crossref","first-page":"620.e1","DOI":"10.1016\/j.ajog.2009.01.038","article-title":"Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women","volume":"200","author":"Austin","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2019111706064804700_B49","first-page":"805","article-title":"Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism","volume":"31","author":"Porter","year":"2014","journal-title":"Am J Perinatol"},{"issue":"6","key":"2019111706064804700_B50","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ajog.2006.02.027","article-title":"Pregnancy loss after first-trimester viability in women with sickle cell trait: time for a reappraisal?","volume":"194","author":"Taylor","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2019111706064804700_B51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0002-9378(75)90933-3","article-title":"Sickle-cell trait and pregnancy: a review of a community hospital experience","volume":"123","author":"Rimer","year":"1975","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2019111706064804700_B52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9378(97)70209-6","article-title":"Women with sickle cell trait are at increased risk for preeclampsia","volume":"177","author":"Larrabee","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2019111706064804700_B53","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jama.1972.03200250044012","article-title":"Low birth weight in babies born to mothers with sickle cell trait","volume":"221","author":"Brown","year":"1972","journal-title":"JAMA"},{"issue":"9","key":"2019111706064804700_B54","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-0528.2008.01776.x","article-title":"Birthweights in sickle cell trait pregnancies","volume":"115","author":"Tan","year":"2008","journal-title":"BJOG"},{"issue":"4","key":"2019111706064804700_B55","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.ajog.2006.11.010","article-title":"Fetal loss and sickle cell trait: a valid association? [corrected]","volume":"196","author":"Tita","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2019111706064804700_B56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2003-37953","article-title":"Pregnant women with the sickle cell trait are not at increased risk for developing preeclampsia","volume":"20","author":"Stamilio","year":"2003","journal-title":"Am J Perinatol"},{"issue":"1","key":"2019111706064804700_B57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0020-7292(90)90649-6","article-title":"Sickle trait and its association with birthweight and urinary tract infections in pregnancy","volume":"33","author":"Baill","year":"1990","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/160\/1249759\/bep00115000160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/160\/1249759\/bep00115000160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:27:53Z","timestamp":1657279673000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2015\/1\/160\/20560\/Sickle-cell-trait-diagnosis-clinical-and-social"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,5]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2015.1.160","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,5]]}}}